243 résultats
2014AUB-9548Ed. Attinger 2014. Bel exemplaire relié, couverture d'origine richement ornée, in-4 (31x25), 239 pages avec annexes dont index des personnes et des agences publicitaires.
2017240786 pieds sous terre, collection Blanche, 2017. Grand in-4, cartonnage couleurs, dos de toile titré. Tout beau tout neuf.
20041251772004 Editions PUF (Presses Universitaires de France) - 2004 - Fort in-8 broché, couverture illustrée - 1362 pages
200689195Berlin ; Heidelberg ; New York : Springer 2006. XI, 222 Seiten. Softcover/Paperback
2002x-0815706316Brookings Inst Pr 2002. Paperback. New. 358 pages. 9.00x6.00x1.00 inches. Brookings Inst Pr paperback
20052136377München: C. H. Beck 1988-2005. XV, 490; XXIV, 872 Seiten. Mit einigen Abbildungen und Tafeln. 8° (17,5-22,5 cm) Orig.-Leinenbände mit Orig.-Schutzumschlag. [Hardcover / fest gebunden].
200462766Washington DC: U. S. Government Printing Office 2004. Presumed first edition/first printing. Wraps. Good. No dust jacket as issued. Front page creasted at corner. iii 179 p. Includes illustrations. Occasional footnotes. Serial No. 108-143. The Committee felt that the flu season had raised the question of whether the country was prepared to deal with a pandemic either a naturally occuring one or as an act of bioterrorism. The hearing examined the actions and planning procedures that had been taken by Federal State and local health officials to handle communicable disease outbreaks. Of particular concern were potential limitations on the vaccine supply. U. S. Government Printing Office paperback
200263981Washington DC: U.S. Government Printing Office 2002. Presumed first edition/first printing. Wraps. Good. No dust jacket as issued. iii 150 p. Includes illustrations. Serial No. 107-34. This hearing docussed on compassionate access to experimentatl drugs. Science dictated a gradual process of information gathering that often took 12 to 15 years from inception to product approval. Part of the process is to move to clinical trials for which formulations are labeled as investigational new drugs and preliminary safety data is obtained and a protocol designed before the clinical trials can move forward. The issue before the Congress was whether patients not part of the trial could otherwise be provided with the experimental drug what might save or extend their lives. U.S. Government Printing Office paperback
200549546Washington DC: GPO 2005. First Edition. First Printing. good. 242 wraps illus. Serial No. 109-57. GPO paperback
2012DADAX1782662693www.Militarybookshop.Co.UK 2012-12-01. hardcover. New. 8.50x0.56x11.00. Buy with confidence. Excellent Customer Service & Return policy. www.Militarybookshop.Co.UK hardcover
2014Atlantic-9780745335162Pluto 2014. Paperback. New. Pluto paperback
2014Atlantic-9780745335162Pluto 2014. Paperback. New. Pluto paperback
200162759Washington DC: U. S. Government Printing Office 2001. Presumed first edition/first printing. Wraps. Good. No dust jacket as issued. iii 95 p. Serial No. 107-2. The hearing was interested in approaches to drug "demand reduction'. U. S. Government Printing Office paperback
200461681Washington DC: U. S. Government Printing Office 2004. Presumed first edition/first printing. Wraps. Very good. No dust jacket as issued. iii 76 p. Illustration. Serial No. 108-111. Well before September 11 2001 the subcommittee had heard testimony from first responders and other experts expressing frustration over the extent and pace of Federal counterterrorism equipment and training programs. Since the September 11 attacks much had been done and much more had been spent to consolidate and focus federal support for first responders. However the subcommittee was concerned that there was a growing body of analysis and commentary suggesting that such increased activity may not be producing enough measurable progress toward actual preparedness. U. S. Government Printing Office paperback
200264433Washington DC: U.S. Government Printing Office 2002. Presumed first edition/first printing. Wraps. Good. No dust jacket as issued. iii 121 p. Illustrations. Map. Serial No. 107-93. U.S. Government Printing Office paperback
200562298Washington DC: U.S. Government Printing Office 2005. Presumed first edition/first printing. Wraps. Very good. No dust jacket as issued. iii 151 p. Includes illustrations. Serial No. 109-99. The Chairman stated that "this hearing may serve to change the course of future drug funding to enable the execution of transit zone drug interdiction operations. " U.S. Government Printing Office paperback
200664516Washington DC: U.S. Government Printing Office 2006. Illustrated. Wraps. Very good. No dust jacket as issued. iii 180 p. Illustrations. Maps. Serial No. 109-193. This hearing explored the use by the Department of Homeland Security of relative risk and effectiveness criteria in their grant award process which produced some unexpected and to some seemingly punitive results. U.S. Government Printing Office paperback
200562344Washington DC: U. S. Government Printing Office 2005. Presumed first edition/first printing. Wraps. Very good. No dust jacket as issued. Has slight wear and soiling. iii 140 p. Illustrations. Occasional Footnotes. Serial No. 109-27. This hearing was held to discuss the roles of the Food and Drug Administration and pharmaceutical companies in ensuring the safety of approved drugs. In particular the hearing examined the post-approval actions taken by the FDA and Merck related to the arthritis and acute pain medication Vioxx. U. S. Government Printing Office paperback
200462773Washington DC: U. S. Government Printing Office 2004. Presumed first edition/first printing. Wraps. Good. No dust jacket as issued. Cover has some wear and soiling. iii 81 p. Serial No. 108-102. The Chairman in opening the hearing noted a recent occurance that illustrated the danger of mercury toxicity and the costs in time and money if facilities needed to be decontaminated. The Chairman was concerned about the dangers of using highly toxic mercury in everyday medical and dental procedures. U. S. Government Printing Office paperback
200148417Washington DC: GPO 2001. First Edition. First Printing. good. 462 wraps illus. Serial No. 107-3. GPO paperback
200351551Washington DC: GPO 2003. First Edition. First Printing. good. 127 wraps tables. Serial No. 107-178. This hearing focused on the cleanup of the Brentwood postal facility after anthrax contamination and on the effects of the contamination and the cleanup on employees and residents. GPO paperback
200442873Washington DC: GPO 2004. good. 163 wraps. Title continues February 3 2004. GPO paperback
200443066Washington DC: GPO 2004. First Edition. First Printing. very good. 220 wraps illus. Serial No. 108-228. GPO paperback
200243079Washington DC: GPO 2002. First Edition. First Printing. very good. 317 wraps illus. Report 107-768. Union Calendar No. 483. Contains minority and additional views. GPO paperback
2001DBS-9781563089459Libraries 2001. 1. Paperback. New. Libraries paperback
